Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bladder Instillations vs Onabotulinumtoxin A for IC/BPS
NCT04401176Phase 2Completed
- Sponsor
- Walter Reed National Military Medical Center
- Start
- Sep 2020
- Primary completion
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A, heparin, lidocaine in interstitial cystitis (IC), bladder pain syndrome (BPS), sponsored by Walter Reed National Military Medical Center. Started Sep 2020; status: completed.
02
Drugs
botulinum toxin type Aheparinlidocaine
03
Conditions
interstitial cystitis (IC)bladder pain syndrome (BPS)
Beyond the preview
Go deeper on NCT04401176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04401176.